MEROPENEM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meropenem, and when can generic versions of Meropenem launch?
Meropenem is a drug marketed by Acs Dobfar, Acs Dobfar Spa, Amneal Pharms, Brooks Steriscience, Daewoong Pharm Co, Eugia Pharma, Gland, Hospira Inc, Hq Spclt Pharma, Qilu, Sandoz, Savior Lifetec Corp, and B Braun Medical Inc. and is included in fourteen NDAs.
The generic ingredient in MEROPENEM is meropenem. There are thirty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meropenem
A generic version of MEROPENEM was approved as meropenem by ACS DOBFAR on October 26th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEROPENEM?
- What are the global sales for MEROPENEM?
- What is Average Wholesale Price for MEROPENEM?
Summary for MEROPENEM
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 137 |
| Patent Applications: | 4,356 |
| Drug Prices: | Drug price information for MEROPENEM |
| What excipients (inactive ingredients) are in MEROPENEM? | MEROPENEM excipients list |
| DailyMed Link: | MEROPENEM at DailyMed |
Recent Clinical Trials for MEROPENEM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scandinavian Critical Care Trials Group | Phase 4 |
| Rutgers Robert Wood Johnson Medical School | Phase 4 |
| Assaf-Harofeh Medical Center | Phase 4 |
Pharmacology for MEROPENEM
| Drug Class | Penem Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for MEROPENEM
US Patents and Regulatory Information for MEROPENEM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acs Dobfar | MEROPENEM | meropenem | INJECTABLE;INJECTION | 091404-002 | Oct 26, 2011 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hq Spclt Pharma | MEROPENEM | meropenem | INJECTABLE;INJECTION | 210773-001 | Aug 16, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Savior Lifetec Corp | MEROPENEM | meropenem | INJECTABLE;INJECTION | 206086-001 | Apr 19, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Brooks Steriscience | MEROPENEM | meropenem | INJECTABLE;INJECTION | 216154-002 | Aug 18, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Acs Dobfar Spa | MEROPENEM | meropenem | INJECTABLE;INJECTION | 204139-001 | Jun 9, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | MEROPENEM | meropenem | INJECTABLE;INJECTION | 205835-001 | Mar 27, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
